TECLens, Inc.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Open Label, Multi-center, Phase I Study of TECLens Quantitative Refractive Crosslinking in Presbyopia-Aged Patients. (NCT07208604) | TECLens, Inc. | 2025-09-30 |
| Quantitative Refractive Crosslinking in Presbyopia Aged Patients (NCT07137767) | TECLens, Inc. | 2025-08-31 |
Track TECLens, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.